Literature DB >> 21107845

Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients.

A Bex1, L Vermeeren, W Meinhardt, W Prevoo, S Horenblas, R A Valdés Olmos.   

Abstract

PURPOSE: To apply single-photon emission computed tomography (SPECT) in combination with computed tomography (CT) for preoperative identification of sentinel lymph nodes (SNs) and to investigate surgical feasibility and safety of intraoperative sampling.
METHODS: A retrospective combined interim analysis of 20 patients from two prospective trials who underwent injection of 99mTc-nanocolloid into the renal tumour for preoperative identification of SN with SPECT/CT and subsequent removal of the tumour and intraoperative sampling using a gamma probe and portable camera. Lymphadenectomy was completed locoregionally. Surgical approach, time, blood loss, intraoperative yield, Clavien complications and anatomical location of SN in correlation with preoperative imaging were evaluated.
RESULTS: SPECT/CT detected SN in 14/20 patients (70%), including 4 patients with non-visualisation on planar lymphoscintigraphy. Twenty-six SNs were seen: 17 para-aortic (including interaorto-caval), 4 retrocaval, 1 hilar, 1 celiac trunc, 1 internal mammary and 2 mediastinal and pleural. These latter 4 nodes were not harvested according to protocol. All other SNs, except for 2 weakly radioactive interaorto-caval nodes, were identified and excised with a mean additional time of 20 min. None of the removed SN and locoregional nodes was tumour-bearing.
CONCLUSIONS: Intraoperative SN identification and sampling in RCC with preoperative detection on SPECT/CT is surgically safe and feasible. SN from the kidney are mainly localised in the para-aortic region, but aberrant nodes receive direct drainage. Non-visualisation of SN appears in almost a third of the patients. Further studies are required to demonstrate whether accurate mapping of lymphatic drainage and extent of lymphatic spread may have diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107845     DOI: 10.1007/s00345-010-0615-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Intrapulmonary lymph node metastasis and renal cell carcinoma.

Authors:  Jalal Assouad; Marc Riquet; Pascal Berna; Claire Danel
Journal:  Eur J Cardiothorac Surg       Date:  2006-11-21       Impact factor: 4.191

2.  Renal lymphatic drainage and thoracic duct connections: implications for cancer spread.

Authors:  J Assouad; M Riquet; C Foucault; G Hidden; V Delmas
Journal:  Lymphology       Date:  2006-03       Impact factor: 1.286

3.  Enlarged hilar and mediastinal nodes (and especially lower right hilar node enlargement) as a sign of metastasis of a renal tumour.

Authors:  F W Wright
Journal:  Clin Radiol       Date:  1977-07       Impact factor: 2.350

4.  Clinically unrecognised renal carcinoma: aspects of tumor morphology, lymphatic and haematogenous metastatic spread.

Authors:  S Hellsten; T Berge; F Linell
Journal:  Br J Urol       Date:  1983-04

5.  Clinical significance of lymph node dissection in renal cell carcinoma.

Authors:  Hideyasu Matsuyama; Hiroshi Hirata; Yoshihito Korenaga; Takashi Wada; Kazuhiro Nagao; Shiro Yamaguchi; Satoru Yoshihiro; Katsusuke Naito
Journal:  Scand J Urol Nephrol       Date:  2005

6.  Feasibility of sentinel node detection in renal cell carcinoma: a pilot study.

Authors:  Axel Bex; Lenka Vermeeren; Geraldine de Windt; Warner Prevoo; Simon Horenblas; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-29       Impact factor: 9.236

7.  Patterns of enlarged lymph nodes in patients with metastatic renal cell carcinoma.

Authors:  David A Hadley; Robert A Stephenson; Wolfram E Samlowski; Christopher B Dechet
Journal:  Urol Oncol       Date:  2010-01-06       Impact factor: 3.498

Review 8.  The role of lymphadenectomy in the surgical management of renal cell carcinoma.

Authors:  Courtney K Phillips; Samir S Taneja
Journal:  Urol Oncol       Date:  2004 May-Jun       Impact factor: 3.498

9.  Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.

Authors:  Allan J Pantuck; Amnon Zisman; Frederich Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara Gitlitz; Arie S Belldegrun; Robert A Figlin
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

10.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

Authors:  Jan H M Blom; Hein van Poppel; Jean M Maréchal; Didier Jacqmin; Fritz H Schröder; Linda de Prijck; Richard Sylvester
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

View more
  11 in total

Review 1.  The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?

Authors:  Karim Bensalah; Morgan Roupret; Evanguelos Xylinas; Shahrokh Shariat
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 2.  The role of lymphadenectomy in the management of renal cell carcinoma.

Authors:  Glen W Barrisford; Boris Gershman; Michael L Blute
Journal:  World J Urol       Date:  2014-04-11       Impact factor: 4.226

3.  The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma.

Authors:  Alessandro Nini; Alessandro Larcher; Walter Cazzaniga; Paolo Dell'Oglio; Francesco Cianflone; Fabio Muttin; Francesco Ripa; Andrea Salonia; Alberto Briganti; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  World J Urol       Date:  2018-11-24       Impact factor: 4.226

Review 4.  The role of lymph node dissection in renal cell carcinoma.

Authors:  Brian F Chapin; Scott E Delacroix; Christopher G Wood
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

Review 5.  The contemporary role of lymph node dissection in the management of renal cell carcinoma.

Authors:  Piotr Zareba; Jehonathan H Pinthus; Paul Russo
Journal:  Ther Adv Urol       Date:  2018-08-20

6.  Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

Authors:  Ciputra Adijaya Hartana; Johan Kinn; Robert Rosenblatt; Stefan Anania; Farhood Alamdari; Hans Glise; Amir Sherif; Ola Winqvist
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

Review 7.  Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?

Authors:  O R Brouwer; H G van der Poel; R F Bevers; E J van Gennep; S Horenblas
Journal:  Clin Transl Imaging       Date:  2016-07-04

8.  An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Authors:  Teele Kuusk; Maarten L Donswijk; Renato A Valdés Olmos; Roderick E De Bruijn; Oscar R Brouwer; Kees Hendricksen; Simon Horenblas; Katarzyna Jóźwiak; Warner Prevoo; Henk G Van Der Poel; Bas W G Van Rhijn; Esther M Wit; Axel Bex
Journal:  EJNMMI Res       Date:  2018-12-03       Impact factor: 3.138

9.  The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Alessandro Nini; Alessandro Larcher; Francesco Cianflone; Francesco Trevisani; Carlo Terrone; Alessandro Volpe; Federica Regis; Alberto Briganti; Andrea Salonia; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  Front Surg       Date:  2018-03-28

Review 10.  Sentinel lymph node imaging in urologic oncology.

Authors:  Sherif Mehralivand; Henk van der Poel; Alexander Winter; Peter L Choyke; Peter A Pinto; Baris Turkbey
Journal:  Transl Androl Urol       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.